Charles River Laboratories International (CRL) Total Current Liabilities (2009 - 2026)

Charles River Laboratories International has reported Total Current Liabilities for 18 years, with the latest figure at $1.1 billion in Q2 2026.

• On a quarterly basis, Total Current Liabilities rose 5.03% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 5.03% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, up 12.7% from the prior year.
• Total Current Liabilities was $1.1 billion for Q2 2026 at Charles River Laboratories International, up from $1.1 billion in the prior quarter.
• The five-year high for Total Current Liabilities was $1.1 billion in Q2 2026, with the low at $947.5 million in Q2 2024.
• Average Total Current Liabilities over 5 years is $1.0 billion, with a median of $1.0 billion recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities rose 23.71% in 2022, then retreated 5.96% in 2024.
• Over 5 years, Total Current Liabilities stood at $1.1 billion in 2022, then retreated by 3.34% to $1.1 billion in 2023, then retreated by 5.78% to $994.1 million in 2024, then rose by 12.7% to $1.1 billion in 2025, then gained by 1.29% to $1.1 billion in 2026.
• The last three Total Current Liabilities figures came in at $1.1 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.